Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medical University of South Carolina
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Must be treatment-seekers
Meet criteria for alcohol use disorder
Must be able to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments
Must use one of the following methods of birth control: oral contraceptives, barrier methods (diaphragm or condoms with spermicide or both), surgical sterilization, use of an intra-uterine contraceptive device, or complete abstinence from sexual intercourse
Must live within a 50-mile radius of our research program and have reliable transportation,
Must consent to remain abstinent from alcohol and all non-prescription drugs prior to medication administration and testing sessions
Must consent to fast for a two-hour period prior to medication administration
Must consent to random assignment to the rapamycin vs. placebo conditions.
You may not be if
Cannot be undergoing other alcohol cessation treatment
Cannot be pregnant, nursing, or of childbearing potential and not using birth control
Cannot have evidence of or a history of significant endocrine, cardiovascular, pulmonary, renal, or neurological disease
Cannot have significant liver impairment
Cannot have an existing infection or immune system disorder
Cannot have a history of or current psychotic disorder, severe major depression, or bipolar affective disorder
Cannot currently take anti-arrythmic agents, psychostimulants, or any other agents known to interfere with heart rate and skin conductance monitoring
Cannot have known or suspected hypersensitivity to macrolide compounds (such as rapamycin/sirolimus)
Cannot currently take medications that could adversely interact with the study medication, including but not limited to significant inhibitors of CYP2D6 or CYP3A4 (voriconazole, fluconazole, itraconazole, erythromycin, clarithromycin, diltiazem, verapamil, etc.), or significant inducers of CYP3A4, such as anticonvulsants (carbamazepine, phenobarbital, phenytoin, etc.) and antibiotics (rifabutin, rifapentine, etc.)
Cannot have a history of thrombocytopenia, idiopathic thrombocytopenia purpura (ITP) or have a platelet count of less than 100,000 cells per mm3
Cannot have any unhealed wounds
Cannot have any planned surgeries within the next month, including surgical dental procedures
Cannot have a history of complicated alcohol withdrawal symptoms (including, but not limited to, symptoms such as seizures, hallucinations, and high blood pressure)